RhythmX AI, a pioneering company in generative artificial intelligence, is transforming the landscape of personalized care with its Precision Care Platform. Led by CEO and founder Deepthi Bathina, the company aims to provide hyperpersonalized care to the right patient at […]
RhythmX AI, a pioneering company in generative artificial intelligence, is transforming the landscape of personalized care with its Precision Care Platform. Led by CEO and founder Deepthi Bathina, the company aims to provide hyperpersonalized care to the right patient at the right time.
Bathina will be participating as a panelist at the upcoming College of Healthcare Information Management Executives Fall Forum on November 11th in Phoenix, Arizona. The panel, titled “Beneficial or Exaggerated? The Covariance of Generative Artificial Intelligence in Healthcare,” will be moderated by Harsh Singh from Genzeon. Alongside Bathina, the panel will feature Diana Nole, CVP of Microsoft Health and Life Sciences; Shakeeb Akhter, Chief Digital and Informatics Officer at a children’s hospital in Philadelphia; and Dr. Safar Chaudry, Chief Digital and Informatics Officer at a children’s hospital in Seattle.
The panel will delve into the rapid transformation of the digital healthcare narrative brought about by generative artificial intelligence. They will discuss case selection processes, success measurement, and the future of AI in healthcare. Through the use of gamification, the panel will evaluate five real-life applications of artificial intelligence, assessing the risks, benefits, and potential for innovation based on an “exaggeration index.”
RhythmX AI has recently garnered attention with its funding and launch announcement. The company, spearheaded by AI entrepreneur Dr. Romesh Wadhwani, founder and CEO of SAIGroup, received an initial investment of $50 million from the AI investment firm. RhythmX AI tackles the $4 trillion annual cost of chronic diseases by providing a platform that empowers doctors to deliver hyperpersonalized care to patients.
Through advanced generative artificial intelligence capabilities and predictive algorithms based on extensive patient data, RhythmX AI equips doctors with patient-specific therapeutic actions and recommendations. These recommendations can be reviewed by doctors using the company’s interface, which incorporates generative artificial intelligence and natural language processing.
About RhythmX AI
RhythmX AI is a generative artificial intelligence company that is reshaping hyperpersonalized care. The company’s Precision Care Platform helps doctors pioneer a new era of holistic care through generative and predictive AI-powered copilots. As a member of SAIGroup, RhythmX AI leverages the resources of the company, including the advanced Eureka AI platform and longitudinal data related to 300 million patients, over 4.4 billion total annual requests, and more than 1.8 million healthcare professionals in over 300,000 facilities. RhythmX AI brings together experts from the healthcare and technology industries, operators, and leading clinical advisors.
SAIGroup is a private investment firm that builds leading artificial intelligence business systems, driving innovation and growth. Its portfolio includes ConcertAI, SymphonyAI, and RhythmX AI, employing over 4,000 people. Dr. Romesh Wadhwani, the founder and CEO, has invested $1 billion in capital investment in SAIGroup.
For more information, please contact Chris Gale at [email protected].
– College of Healthcare Information Management Executives: [Link]
– PRNewswire: [Link]
– SAIGroup: [Link]
1. Who will be present on the panel at the College of Healthcare Information Management Executives Fall Forum?
The panel will include Deepthi Bathina, Diana Nole, Shakeeb Akhter, and Dr. Safar Chaudry.
2. What will be discussed on the panel?
The panel will discuss the implementation of generative artificial intelligence in healthcare and evaluate the risks, benefits, and innovative potential of this technology.
3. Who funded RhythmX AI?
RhythmX AI was funded by the investment firm, SAIGroup, with an initial investment of $50 million.
4. What does RhythmX AI offer to doctors?
RhythmX AI provides doctors with advanced generative artificial intelligence capabilities and predictive algorithms based on extensive patient data, enabling patient-specific therapeutic actions and recommendations.